Back to Search
Start Over
Anti-tumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myeloma.
- Source :
-
Leukemia [Leukemia] 2015 Feb; Vol. 29 (2), pp. 510-4. Date of Electronic Publication: 2014 Oct 13. - Publication Year :
- 2015
- Subjects :
- Animals
Apoptosis
Bortezomib
Cell Line
Cell Line, Tumor
Cell Proliferation
Cell Survival
Drug Screening Assays, Antitumor
Humans
Mice
Mice, SCID
Monomeric GTP-Binding Proteins metabolism
Mutation
Neoplasm Transplantation
Retinal Pigment Epithelium cytology
Antineoplastic Agents administration & dosage
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Benzamides administration & dosage
Boronic Acids administration & dosage
HSP90 Heat-Shock Proteins antagonists & inhibitors
Multiple Myeloma drug therapy
Pyrazines administration & dosage
Pyrazoles administration & dosage
Subjects
Details
- Language :
- English
- ISSN :
- 1476-5551
- Volume :
- 29
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Leukemia
- Publication Type :
- Report
- Accession number :
- 25306900
- Full Text :
- https://doi.org/10.1038/leu.2014.300